HORSHAM, Pa., April 27, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the treatment of serious dermatological disorders, and best-in-class products for the medical aesthetic market, will release first quarter financial results on Thursday, May 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, May 11 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 888-857-6930 |
| International: | 719-325-2432 |
| Passcode: | 3263032 |
| Webcast: | www.strataskinsciences.com |
| Replays, available through May 25, 2017 | |
| Toll Free: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 3263032 |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and medical-aesthetic dermatology market. STRATA sales include the following products: the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystems, a micropigmentation device which provides advanced technology and exceptional results; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.